Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic implications of leukemia stem cell development.

Matthew C Stubbs1, Scott A Armstrong

  • 1Division of Hematology/Oncology, Children's Hospital Boston, Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|June 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Menin-MLL inhibitors enhance JUND activity in MLLr leukemic cells contributing to tumorigenesis and therapy resistance.

Blood·2026
Same author

CRISPR base editor screening identifies spectrum of MEN1 mutations impacting menin inhibitors in clinical trials.

Nature communications·2026
Same author

Combining menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia.

Blood advances·2026
Same author

Genetic variation reveals a homeotic long noncoding RNA that modulates human hematopoietic stem cells.

Cell·2026
Same author

High-throughput ligand diversification to discover chemical inducers of proximity.

Nature chemical biology·2026
Same author

Metabolic control of innate immune activation in TET2-mutant clonal hematopoiesis.

Cell chemical biology·2026

Cancer stem cells, including leukemia stem cells (LSC), drive cancer growth. Understanding their origins and characteristics is key to developing new cancer therapies.

Area of Science:

  • Hematology
  • Cancer Biology
  • Stem Cell Research

Background:

  • Cancer, particularly acute myelogenous leukemia, is sustained by cancer stem cells.
  • These cells possess self-renewal and differentiation capabilities.
  • Recent research illuminates the origins and nature of leukemia stem cells (LSC).

Purpose of the Study:

  • To review the potential hematopoietic cells that can give rise to leukemia stem cells (LSC).
  • To describe the phenotype of fully developed leukemia stem cells (LSC).
  • To discuss the implications of LSC development pathways for novel therapeutic strategies.

Main Methods:

  • Literature review of recent discoveries on leukemia stem cells.
  • Analysis of hematopoietic cell origins for LSC development.

Related Experiment Videos

  • Examination of LSC phenotype and developmental context.

    • Main Results:

    • Identification of potential cell-of-origin candidates for LSC.
    • Characterization of the phenotype of established LSC.
    • Understanding of the perturbed developmental pathways involved in LSC formation.

    Conclusions:

    • The cellular origin and developmental pathways of LSC are critical areas of study.
    • Targeting LSC development holds promise for new cancer treatments.
    • Further research into LSC biology can inform therapeutic advancements.